1. Sertkaya A, Birkenbach A, Berlind A, Eyraud J. Examination of Clinical Trial Costs and Barriers for Drug Development Washington DC: Office of the Assistant Secretary for Planning And Evaluation, U.S. Department of Health and Human Services; 2014 [Available from:
https://aspe.hhs.gov/report/examination-clinical-trial-costs-and-barriers-drug-development
.
2. RTI International - University of North Caroline Evidence-based Practice Center. Communication and Dissemination Strategies to Facilitate the Use of Health-related Evidence. Rockville, USA: Agency for Healthcare Research and Quality, US Department of Health and Human Services, 2013 November 2013. Report No.: Contract No.: 213.
3. Fernandez CV, Kodish E, Weijer C. Informing study participants of research results: an ethical imperative. Irb. 2003;25(3):12–9.
4. Partridge AH, Wong JS, Knudsen K, Gelman R, Sampson E, Gadd M, et al. Offering participants results of a clinical trial: sharing results of a negative study. Lancet. 2005;365(9463):963–4.
5. Shalowitz DI, Miller FG. Communicating the results of clinical research to participants: attitudes, practices, and future directions. PLoS Med. 2008;5(5):e91.